Tissue Elastography Assessement and Cuteous and Cubcutaneous Thickness Measurement Following Manual Lymph Drainage in Legs With Lymphedema
ELASTOLYMPH
Interest of the Ultrasound Follow-up of Lymphedema by Elastography Assessment and Cutaneous and Subcutaneous Thickness Measurement During Intensive Treatment of Lymphedema.
1 other identifier
observational
47
1 country
1
Brief Summary
Tissue Elastography Assessement and Cuteous and Cubcutaneous Thickness Measurement Following Manual Lymph Drainage in Legs With Lymphedema Hence the importance of evaluating the impact of an intensive five-day decongestive treatment on lymphedema in terms of cutaneous flexibility and edema regression. Patients who are undergoing intensive decongestive treatment for four or five days in the department perform an ultrasound check/examiantion on the first day. During this echography, in 5 usual measurement points are made an ultrasound image recording (for measurement of cutaneous and subcutaneous thicknesses) and an elastography sequence (an instantaneous measurement). The study hypothesis is to note that intensive decongestive treatment has an impact on tissues flexibility and cutaneous and subcutaneous thickness. No many authors discussed this suject, hence the interest of this study. All the data collected and the results obtained will serve for further studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2019
CompletedFirst Submitted
Initial submission to the registry
November 12, 2021
CompletedFirst Posted
Study publicly available on registry
January 11, 2022
CompletedJanuary 11, 2022
December 1, 2021
3 months
November 12, 2021
December 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
number of Elastography
number of Elastography
day 1 (pre treatment)
number of Elastography
number of Elastography
day 5 (post treatment)
Secondary Outcomes (6)
number of Cutaneous thicknesses
day 1 (pre treatment)
number of Cutaneous thicknesses
day 5 (post treatment)
number of Subcutaneous thicknesses
day 1 (pre treatment)
number of Subcutaneous thicknesses
day 5 (post treatment)
number of Limb volumetry
day 1 (pre treatment)
- +1 more secondary outcomes
Study Arms (1)
Patients hospitalized for treatment of lymphoedema
Patients hospitalized for treatment of lymphoedema
Interventions
Ultrasonography / Ultrasound elastography
Eligibility Criteria
Patients receinving intensive treatment for lower limb lymphedema at UHC Saint Eloi. Patients with lower limb lymphedema coming to UHC Saint Eloi for intensive treatment.
You may qualify if:
- Major patients with unilateral or bilateral lymphedema of the lower limb (s), stage II or III, of primary or secondary origin
- Major patients with admitted for the realization of an Intensive Decongestive Treatment (TDI) of three to five days in the lymphology unit of the Saint Eloi hospital, of Montpellier UHC.
You may not qualify if:
- Patients with different lymphedema localisation than the lower limbs
- Patient with amputated
- patient not consenting or included in another clinical research study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Uhmontpellier
Montpellier, 34295, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
MESTRE GODIN Sandrine
University Hospital, Montpellier
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2021
First Posted
January 11, 2022
Study Start
May 1, 2019
Primary Completion
August 1, 2019
Study Completion
October 20, 2019
Last Updated
January 11, 2022
Record last verified: 2021-12